Pleiotrophin Expression in Human Pancreatic Cancer and Its Correlation with Clinicopathological Features, Perineural Invasion, and Prognosis

Jun Yao,Qingyong Ma,Liancai Wang,Min Zhang
DOI: https://doi.org/10.1007/s10620-008-0433-5
2008-01-01
Digestive Diseases and Sciences
Abstract:Pleiotrophin (PTN), a heparin-binding growth factor also known as neurite growth-promoting factor, exhibits several properties related with tumor development. PTN and its receptor, N -syndecan, may play a very important role in tumor growth and neural invasion of pancreatic cancer. We investigated PTN and N -syndecan protein levels in 38 patients with pancreatic cancer by immunohistochemistry, and analyzed for its correlation with clinicopathological features, perineural invasion, and prognosis. The results showed that PTN and N -syndecan proteins were found in 24 (63.2%) and 22 (57.9%) specimens, respectively. PTN and N -syndecan expressions were associated with perineural invasion ( P = 0.016 and P = 0.029, respectively). High PTN expression was closely related to an advanced TNM stage ( P = 0.007), lymph node metastasis ( P = 0.040), and decreased postoperative survival at 3 years (50.0% versus 20.8%, respectively; P = 0.001). We conclude that high expression of PTN combined with N -syndecan may contribute to the increased perineural invasion and poor prognosis of pancreatic cancer.
What problem does this paper attempt to address?